About
I am an Associate Professor in the Department of Biosciences at Integral University. My research interests encompass nanotechnology, nanomedicine, microbiology, neurodegenerative diseases, targeted drug delivery, antimicrobial resistance, the green synthesis of functional nanomaterials, and the development of experimental models for diabetes and Alzheimer's disease. Through interdisciplinary research, I aim to bridge the gap between natural product-based therapeutics and advanced nanotechnology, contributing to the development of next-generation treatments for complex human diseases.
Employment
-
Integral University Associate Professor2013 - Present
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (54)
- Bioengineered gold nanoparticles strengthens antioxidant defense and enhance shelf life of tomato fruits Save
- Amino Acid–Driven Gold Nanochaperone Platforms for Alzheimer’s Therapy: A Mechanistic and Design Framework for Protein Misfolding Modulation Save
- Green Synthesis of Zinc Oxide and Gold Nanoparticles Using Daucus carota Root Extract and Their Antibacterial and Anticancer Potential Save
- Green synthesis of silver nanoparticles and their potential for antimicrobial application Save
- Unlocking the Bioactive Potential of Lawsonia inermis: Eco-Friendly Silver Nanoparticles with Dual Antimicrobial and Anticancer Efficacy Save
- Biofunctionalized zinc nanoparticles from Alangium salvifolium seeds extract: a potent antibacterial and anti-Cancer therapeutic agent Save
- Fisetin as a multifunctional bioactive flavonoid: A comprehensive review of its pharmacology, mechanism of action, safety profile, clinical trials, and future directions in therapeutics Save
- Natural anti-aging innovations: Bakuchiol role in longevity and stress resilience through DAF-16 pathway activation Save
- Plant-based secondary metabolites as natural remedies: a comprehensive review on terpenes and their therapeutic applications Save
- Nano‐Chaperones: Bridging Therapeutics for Amyloid Aggregation in Alzheimer's Disease and Type‐2 Diabetes Mellitus Save